Sanna Bastiano's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed May 4, 2023
- Accession no.
- 0001209191-23-027374
- Filed
- May 4, 2023
- Trade date
- May 2-3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $1.54M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sanna BastianoCIK 0001829069 | Officer (EVP, Cell & Genetic Therapies) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | Common Stock | SSaleDisposed | −1,411 | $350.32F2,F3 | −$494,301.52 | 38,302 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −42 | $351.65F2,F4 | −$14,769.3 | 38,260 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −169 | $353.24F2,F5 | −$59,697.56 | 38,091 | Direct | |
| May 3, 2023 | Common Stock | SSaleDisposed | −2,053 | $350.44F2,F6 | −$719,453.32 | 36,038 | Direct | |
| May 3, 2023 | Common Stock | SSaleDisposed | −728 | $351.60F2,F7 | −$255,964.8 | 35,310 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $350.32 (range $350.00 to $350.92).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $351.65 (range $351.48 to $351.80).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $353.24 (range $353.21 to $353.49).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $350.44 (range $350.00 to $350.94).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $351.60 (range $351.01 to $352.00).
Referenced by the price of 1 transaction in Table I.